Neoadjuvant concurrent or sequential anthracycline-containing chemotherapy and HER2-targeted agents for HER2-positive breast cancer: a randomized phase 2 study (METIS)
Source Nature 医学研究1d ago
Summary
We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.
Open original- Desk
- Health
- Region
- Global
- Language
- English
- Item ID
- health-39a0fe5c
Comments 0 comments
No comments yet. Be the first.